Conditions: Type 2 Diabetes
Keywords: diabetes type 2
Allocation: NON_RANDOMIZED | Intervention model: PARALLEL
Enrollment: 598
Healthy volunteers: no

Brief summary:
This study will assess if customizing the start dose of rosuvastatin appropriate for the degree of LDL-C reduction required, would achieve LDL-C target of ≤ 2.0 mmol/L quickly with either no titration or just one titration step after 6 weeks of therapy in type 2 diabetic patients previously treated with another statin and not at LDL-C targets.

Detailed description:

Arms:
arm 1: titrated arm 2: Non-titrated

Interventions: intervention 1: Rosuvastatin
Intervention descriptions: intervention 1: Oral

Protocol document: